GlassScriptPhysician profile
William Marcus Brann
NPI 1912087826
$2,402.91
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.59 · 2020: $60.43 · 2021: $334 · 2022: $743 · 2023: $833 · 2024: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,209.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $410.80 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $388.04 | 2020-2023 | |
| Boston Scientific Corporation | $369.75 | 2019-2023 | Watchman Flx |
| Merck Sharp & Dohme LLC | $132.85 | 2021-2024 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $127.00 | 2022-2023 | Opsumit, Uptravi |
| Cvrx, INC. | $107.03 | 2021-2023 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $71.56 | 2023 | Xarelto |
| Irhythm Technologies, INC. | $67.70 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Baxter Healthcare | $65.79 | 2022-2024 | Hillrom - Carnation Ambulatory Monitor |
| Philips North America LLC | $56.96 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.45 | 2023-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $51.25 | 2023-2024 | Eliquis, Camzyos |
| Depuy Synthes Sales INC. | $38.59 | 2022 | |
| Mallinckrodt Hospital Products INC. | $38.57 | 2022 | |
| Endologix LLC | $35.79 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $33.95 | 2023-2024 | Inspire |
| Atricure, INC. | $30.07 | 2023-2024 | |
| Bardy Diagnostics, INC. | $29.27 | 2022 | |
| Idorsia Pharmaceuticals US INC | $29.02 | 2023 | Quviviq |
| Itamar Medical INC | $28.34 | 2024 | Watchpatone |
| Lexicon Pharmaceuticals, INC. | $27.44 | 2024 | |
| Viiv Healthcare Company | $23.82 | 2019 | |
| Intuitive Surgical, INC. | $23.16 | 2022 | |
| Grifols USA, LLC | $20.88 | 2024 | Prolastin-C Liquid |
| Medtronic, INC. | $20.34 | 2021 | |
| Active Medical, LLC | $19.58 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.94 | 2024 | |
| Electromed, INC. | $18.68 | 2024 | Smartvest |
| Acell, INC. | $18.59 | 2020 | |
| Acera Surgical, INC. | $17.98 | 2023 | Restrata Wound Matrix |
| Amarin Pharma, INC. | $16.61 | 2020 | |
| Novo Nordisk INC | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Brann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.